Roche Holding AG (RHHBY)

OTCMKTS · Delayed Price · Currency is USD
45.40
+0.25 (0.55%)
Oct 8, 2025, 3:59 PM EDT
0.55%
Market Cap311.99B
Revenue (ttm)79.83B
Net Income (ttm)11.86B
Shares Outn/a
EPS (ttm)14.77
PE Ratio26.31
Forward PE15.41
Dividend0.87 (1.93%)
Ex-Dividend DateMar 28, 2025
Volume453,828
Average Volume1,518,996
Open45.84
Previous Close45.15
Day's Range45.21 - 45.90
52-Week Range34.10 - 45.94
Beta0.18
RSI68.15
Earnings DateOct 20, 2025

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagn... [Read more]

Sector Healthcare
Founded 1896
Employees 103,249
Stock Exchange OTCMKTS
Ticker Symbol RHHBY
Full Company Profile

Financial Performance

In 2024, Roche Holding AG's revenue was 62.40 billion, an increase of 3.23% compared to the previous year's 60.44 billion. Earnings were 8.28 billion, a decrease of -28.01%.

Financial numbers in CHF Financial Statements

News

89bio Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNB

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of ...

2 days ago - Business Wire

My Top 5 Biotech Stocks Big Pharma Could Buy Next

While AI hype reigns on Wall Street, the healthcare sector is still far from the peaks it reached during the COVID-19 pandemic. And what's more important, many of the biotech stocks remain outside of ...

2 days ago - Seeking Alpha

Roche Wins FDA Nod for Label Expansion of Tecentriq in Lung Cancer

Roche gains FDA approval for Tecentriqs expanded label, marking the first combo maintenance therapy for extensive-stage small cell lung cancer.

2 days ago - Nasdaq

Roche receives CE Mark for AI-based Kidney Klinrisk Algorithm(1) and launches new comprehensive chronic kidney disease (CKD) algorithm panel

Basel, 6 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY), in collaboration with KlinRisk, Inc., has received the CE-mark for the first AI-based risk stratification tool to assess progressive decline...

2 days ago - GlobeNewsWire

FDA Approves Roche's Tecentriq for Lung Cancer Treatment

FDA Approves Roche's Tecentriq for Lung Cancer Treatment

5 days ago - GuruFocus

FDA approves Roche's Tecentriq plus lurbinectedin as first-line maintenance therapy for extensive-stage small cell lung cancer

Basel, 3 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Tecentriq® (atezolizumab) and Tecentriq Hybreza® (atezolizumab ...

5 days ago - GlobeNewsWire

Change in the Roche Board of Directors

Basel, 3 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Dr. Claudia Süssmuth Dyckerhoff has decided not to stand for re-election as a member of the Roche Board of Directors at ...

5 days ago - GlobeNewsWire

FDA Approves Genentech's Tecentriq Plus Lurbinectedin as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Tecentr...

5 days ago - Business Wire

Roche Launches Tender Offer To Acquire 89bio For $14.50/shr Plus CVR

(RTTNews) - Roche (RHHBY, RO.SW, ROG.SW) announced that it has launched a tender offer to acquire all outstanding common shares of 89bio, Inc. (ETNB). The offer includes a cash payment of $14.50 per s...

6 days ago - Nasdaq

Trade treaty kicks in, Swiss govt seeks investment pact

EFTA Bloc nations pledged $100 billion investments in India under a new trade deal, with Switzerland seeking a bilateral investment treaty and Liechtenstein a double taxation avoidance agreement. Phar...

6 days ago - The Times of India

Roche Initiates Tender Offer for 89bio (ETNB) in $3.5B Acquisition

Roche Initiates Tender Offer for 89bio (ETNB) in $3.5B Acquisition

6 days ago - GuruFocus

Roche begins tender offer for 89bio as part of acquisition

Roche launches $3.5B tender offer for 89bio shares, including milestone payments. Learn key deal details and deadlines.

7 days ago - Seeking Alpha

Roche commences tender offer for all shares of 89bio, Inc. for $14.50 per share in cash, plus a non-tradeable contingent value right for up to $6.00 per share in cash

Basel, 1 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has commenced a tender offer for all of the outstanding shares of common stock of 89bio, Inc. (89bio) (NASDAQ: ETNB) ...

7 days ago - GlobeNewsWire

Novo Nordisk, Roche gain upgrades from HSBC

HSBC upgrades Novo Nordisk and Roche to buy, citing strong drug pipelines and growth prospects. Read more here.

7 days ago - Seeking Alpha

Swiss pharma companies eye follow up to Pfizer-US pricing deal, business lobby says

GENEVA (Reuters) -Swiss drugmakers could strike their own deals with the U.S. after President Donald Trump's push to lower prescription drug prices led to an accord with Pfizer in exchange for tariff ...

7 days ago - Yahoo

Roche's Troponin T Test Offers New Level Of Accuracy Critical For Diagnosing Heart Attacks

(RTTNews) - Roche (RHHBY) Tuesday announced the primary results from the TSIX Study Program, which evaluated the performance of its new sixth-generation high-sensitivity Troponin T test for diagnosing...

8 days ago - Nasdaq

Labcorp Collaborates With Roche To Implement VENTANA DP 600 And DP 200 Slide Scanners

(RTTNews) - Labcorp (LH) announced a collaboration with Roche to implement the company's FDA-cleared VENTANA DP 600 and DP 200 slide scanners. The investment enables pathologists to diagnose patients ...

8 days ago - Nasdaq

Data show Roche's sixth-generation Troponin T test offers a new level of accuracy critical for diagnosing heart attacks

Basel, 30 September 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the primary results from the TSIX Study Program, which evaluated the performance of its new sixth-generation high-sensitivity Tr...

8 days ago - GlobeNewsWire

Emma Walmsley To Step Down As GSK CEO After Nine Years, Luke Miels To Lead Starting January 2026

GSK plc (NYSE: GSK) appointed Luke Miels as the CEO Designate of GSK. He will assume full responsibility as CEO and join the Board on January 1, 2026. Luke will succeed the current CEO, Dame Emma Wal...

9 days ago - Benzinga

Roche points to U.S. plans after Trump pharma tariff announcement

Switzerland's Roche on Friday pointed to the fact that one of its U.S. units broke ground on a new facility in August and that the pharma company had pledged major U.S. investments after President Don...

12 days ago - Reuters

Kodiak gains as Barclays upgrades on Roche data for eye disease drug

Kodiak Sciences (KOD) stock gains as Barclays upgrades the company, citing a positive read-through from a recent trial readout from Roche (RHHBY). Read more here.

13 days ago - Seeking Alpha

Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial

Roche Pharmaceuticals' CEO told investors she was "serious" about the goal of becoming a top 3 obesity player.

13 days ago - CNBC